𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C virus genotypes and response to interferon in patients with chronic hepatitis C

✍ Scribed by T. Goeser; S. Rossol; U. Töx; B. Kallinowski; W. Stremmel; L. Theilmann

Book ID
118881594
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
162 KB
Volume
108
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genotypes and titers of hepatitis C viru
Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C
✍ Kunihiko Hino; Shigehiko Sainokami; Kazumi Shimoda; Shiro Iino; Yu Wang; Hiroaki 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

## Abstract Interferon induces remission in about 50% of patients with chronic hepatitis C, but it is difficult to predict which patients will respond. Host and viral factors were evaluated for correlation with response to interferon in patients with chronic hepatitis C. Recombinant interferon alph

Relationship of the genomic complexity o
Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon
✍ Francesc-Xavier López-Labrador; Sergi Ampurdanès; Mireia Giménez-Barcons; Magdal 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 3 views

In patients with chronic hepatitis C, the influence of the genetic heterogeneity of the hepatitis C virus (HCV) on the progression of liver disease and on the responsiveness to interferon therapy is a matter of controversy. In this study we evaluated the genetic complexity of HCV by singlestrand con

Usefulness of simple assays for serum co
Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy
✍ Toshio Suzuki; Eiji Tanaka; Akihiro Matsumoto; Akihiko Urushihara; Takeshi Sodey 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

## Abstract The use of two new assays was evaluated for predicting the response to interferon (IFN) therapy in patients with chronic hepatitis C. The genotype of hepatitis C virus (HCV) was establishe by an enzyme‐linked immunosorbent assay based on genotype‐specific recombinant peptides of the NS4